Because SPATA5 acts in mammalian sperm development and is expressed in testes, we posed the hypothesis that NlSPATA5 occurs in BPH seminal fluid and it operates in fecundity via mating. The gene discussed is AFG2A; the disease is benign prostatic hyperplasia.